Table 3.
Hu-D peptides | Hu+ patients | Hu− donors |
---|---|---|
58–66 | 1/3 | 0/4 |
64–72 | 0/6 | 0/4 |
86–95 | 1/6 | 0/4 |
88–95 | 2/5 | 0/3 |
111–119 | 1/6 | 0/4 |
134–143 | 2/5 | 0/3 |
147–155 | 2/3 | 1/4 |
151–158 | 2/5 | 0/3 |
154–163 | 4/5 | 0/3 |
163–171 | 1/6 | 0/4 |
176–184 | 4/5 | 0/3 |
245–254 | 2/6 | 2/6 |
248–256 | 2/6 | 0/4 |
272–281 | 0/2 | 0/4 |
305–313 | 0/2 | 0/4 |
315–323 | 2/6 | 0/4 |
341–348 | 3/5 | 0/3 |
347–355 | 0/4 | 1/4 |
362–370 | 2/6 | 0/4 |
Results are expressed as numbers of donors having T cells secreting IFN-γ in the presence of one Hu-D peptide in the ELISPOT assay. Results presented in bold characters correspond to peptides recognized by T cells of Hu-positive patients only.